Bioventus BVS

Bioventus Inc. · Nasdaq · Surgical & Medical Instruments & Apparatus

$10.95-16.77%close on Nov. 3, 2026 · volume 2.4M · Yahoo Finance

Price, last 51 sessions

$12.00$14.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 3, 2026 · high $15.04 · low $10.95 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 6 →
  • 10-QNov. 2, 2026, 4:20 p.m. ETView on SEC.gov
  • 8-KNov. 2, 2026, 4:12 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedBioventus Q3 2026 adjusted EPS of $0.17 beats $0.16 consensus, but revenue of $142.4 million misses $149.5 million estimate and full-year sales guidance of $590 million to $595 million sits below $604.8 million consensus

  • SCHEDULE 13G/AOct. 27, 2026, 5:25 p.m. ETView on SEC.gov
  • 10-QAug. 5, 2026, 7:43 a.m. ETView on SEC.gov
  • 8-KAug. 5, 2026, 7:40 a.m. ETView on SEC.gov

    Results of operations and financial condition · Other events · Financial statements and exhibits

  • SCHEDULE 13GJuly 27, 2026, 4:25 p.m. ETView on SEC.gov